CG Oncology, Inc. (CGON)
74.67
+0.34
(+0.46%)
USD |
NASDAQ |
Sep 04, 16:00
74.64
-0.03
(-0.04%)
After-Hours: 20:00
CG Oncology Market Cap : 6.594B for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 6.594B |
| September 03, 2026 | 6.564B |
| September 02, 2026 | 6.587B |
| September 01, 2026 | 6.699B |
| August 31, 2026 | 6.637B |
| August 28, 2026 | 6.565B |
| August 27, 2026 | 6.977B |
| August 26, 2026 | 6.925B |
| August 25, 2026 | 6.972B |
| August 24, 2026 | 6.908B |
| August 21, 2026 | 7.048B |
| August 20, 2026 | 6.853B |
| August 19, 2026 | 7.125B |
| August 18, 2026 | 6.737B |
| August 17, 2026 | 6.809B |
| August 14, 2026 | 6.626B |
| August 13, 2026 | 6.597B |
| August 12, 2026 | 6.799B |
| August 11, 2026 | 6.802B |
| August 10, 2026 | 6.761B |
| August 07, 2026 | 6.632B |
| August 06, 2026 | 6.610B |
| August 05, 2026 | 6.395B |
| August 04, 2026 | 6.305B |
| August 03, 2026 | 6.086B |
| Date | Value |
|---|---|
| July 31, 2026 | 6.265B |
| July 30, 2026 | 6.427B |
| July 29, 2026 | 6.083B |
| July 28, 2026 | 6.391B |
| July 27, 2026 | 6.470B |
| July 24, 2026 | 6.101B |
| July 23, 2026 | 6.259B |
| July 22, 2026 | 6.100B |
| July 21, 2026 | 6.312B |
| July 20, 2026 | 6.177B |
| July 17, 2026 | 6.323B |
| July 16, 2026 | 6.117B |
| July 15, 2026 | 6.425B |
| July 14, 2026 | 6.316B |
| July 13, 2026 | 6.381B |
| July 10, 2026 | 6.622B |
| July 09, 2026 | 6.453B |
| July 08, 2026 | 6.143B |
| July 07, 2026 | 6.090B |
| July 06, 2026 | 6.095B |
| July 02, 2026 | 6.192B |
| July 01, 2026 | 6.239B |
| June 30, 2026 | 6.253B |
| June 29, 2026 | 6.489B |
| June 26, 2026 | 6.333B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.709B |
| Arrowhead Pharmaceuticals, Inc. | 12.19B |
| Oncolytics Biotech, Inc. | 105.09M |
| Sangamo Therapeutics, Inc. | 66.70M |
| Sarepta Therapeutics, Inc. | 2.377B |
Market Cap Related Metrics
| PS Ratio | 987.77 |
| PEG Ratio | -0.485 |
| Price to Book Value | 6.407 |
| Price | 74.67 |
| Earnings Yield | -3.61% |
| PEGY Ratio | -0.485 |